je.st
news
Tag: recombinant
Kraig Biocraft develops recombinant spider silk cocoons
2018-04-04 12:55:00| Daily apparel & textile news and comment - from just-style.com
Kraig Biocraft Laboratories, the leading developer of spider silk based fibres, has successfully produced what it says is the first recombinant spider silk cocoons from a new line of hybrid transgenic silkworms developed at its new R&D centre.
Tags: spider
develops
silk
recombinant
Streamlining Recombinant Protein Production
2016-03-23 15:02:24| drugdiscoveryonline Home Page
Use of recombinant proteins as therapeutics has become an attractive strategy for altering the biology of disease progression and offers significant commercial opportunities. However, bringing a recombinant protein to market requires a substantial investment of time and resources, and the process is generally complex and subject to technical pitfalls.
Tags: production
protein
recombinant
streamlining
Streamlining Recombinant Protein Production
2016-03-23 15:02:24| drugdiscoveryonline Downloads
Use of recombinant proteins as therapeutics has become an attractive strategy for altering the biology of disease progression and offers significant commercial opportunities. However, bringing a recombinant protein to market requires a substantial investment of time and resources, and the process is generally complex and subject to technical pitfalls.
Tags: production
protein
recombinant
streamlining
Baxter BioScience Announces Positive Phase III Results For BAX 817, Investigational Recombinant Treatment For Hemophilia A And B Patients With Inhibitors
2015-04-01 07:33:48| drugdiscoveryonline Home Page
Baxter International Inc. recently announced positive results from its Phase III clinical trial evaluating the safety and efficacy of BAX 817, an investigational recombinant factor VIIa (rFVIIa) treatment for people with hemophilia A or B who develop inhibitors
Tags: with
results
iii
positive
Bayer Initiates Phase III Trial of an Investigational Recombinant...
2013-07-09 06:27:42| Chemicals - Topix.net
Bayer HealthCare today announced the company has started to enroll patients in an international Phase II/III trial to evaluate its investigational compound BAY94-9027 for the treatment of hemophilia A in children.